Additionally, hsa-miR-219-5p was found to be regulated by IL-3, GM-CSF and G-CSF in acute myeloid leukaemia6, and it inhibits HCC cell proliferation through cell cycle arrest by targeting glypican-328. The gene discussed is CSF3; the disease is hepatocellular carcinoma.